시장보고서
상품코드
1880712

바이오엔지니어링 기술 시장 기회 및 전략(-2034년)

Bioengineering Technology Global Market Opportunities And Strategies To 2034

발행일: | 리서치사: The Business Research Company | 페이지 정보: 영문 397 Pages | 배송안내 : 2-3일 (영업일 기준)

    
    
    




■ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송일정은 문의해 주시기 바랍니다.

세계의 바이오엔지니어링 기술 시장은 2024년에 약 3,203억 8,084만 달러의 규모에 이르렀으며, 2019년 이후 13.45%의 연평균 복합 성장률(CAGR)로 성장해 왔습니다. 이 시장은 2024년 3,203억 8,084만 달러에서 2029년에는 5,651억 6,447만 달러로 12.02%의 성장률로 확대될 것으로 예측됩니다. 그 후 2029년 이후 CAGR 10.26%를 나타내 2034년에는 9,208억 3,880만 달러에 이를 것으로 예상됩니다.

바이오엔지니어링 기술은 의료, 농업, 산업 분야에서 혁신적인 제품, 프로세스 및 솔루션 개발을 목적으로 생물학적 시스템과 생물에 공학 원리와 기술을 적용하는 것입니다. 바이오테크놀러지, 재료과학, 전자공학, 컴퓨팅 모델링 등의 분야를 통합하여 의학, 유전학, 환경 지속가능성, 바이오제조의 과제에 임하고 있습니다. 바이오엔지니어링 기술의 주요 목적은 인간의 건강을 향상시키고, 삶의 질을 향상시키고, 지속가능성을 증진시키는 것입니다.

세포 치료에 대한 관심 증가

세포 요법에 대한 관심 증가는 과거 기간 동안 바이오엔지니어링 기술 시장의 성장을 이끌었습니다. 세포 요법이 세포 배양, 유전 공학 및 바이오프로세싱을위한 고급 도구를 필요로하기 때문에이 분야에 대한 관심 증가는 바이오엔지니어링 기술 시장을 활성화하고 있습니다. 재생 의료 및 개인화 치료에 대한 투자 확대는 바이오엔지니어링 솔루션의 혁신과 보급을 더욱 촉진하고 있습니다. 예를 들어, 2024년 4월에 미국 유전자·세포 치료 학회(ASGCT)가 발표한 데이터에 의하면, 4분기(Q4)에 있어서 III상 임상시험 단계의 유전자 치료수는 10% 증가해, 2022년 3분기(Q3) 이래가 되는 분기 베이스에서의 최초의 성장을 기록했습니다. 따라서 세포치료에 대한 주목 증가가 바이오엔지니어링 기술 시장의 성장을 견인했다고 할 수 있습니다.

자동 조직 분리 시스템은 세포 치료 및 조사 효율성 향상

바이오엔지니어링 기술 시장의 주요 기업은 세포 기반 요법과 바이오 제조의 효율화를 도모하기 위해 높은 생존율과 세포 수율을 향상시키기 위해 노력하고 있습니다. 이러한 혁신은 생산 비용 절감, 확장성 강화, 첨단 치료법 개발 가속화를 목표로 하고 있습니다. 예를 들어, 2025년 6월에는 캐나다에 본사를 둔 생명공학 기업인 STEMCELL Technologies가 STEMprep 조직 분산 시스템을 발표했습니다. 이것은 고형 조직을 고품질의 단일 세포 현탁액으로 변환하는 조직 분산을 자동화 및 표준화하는 탁상 장치입니다. 시간 단축과 일관성 향상을 위해 설계된 STEMprep은 세포 무결성과 기능성을 유지하고 정확한 분리 및 분석을 지원합니다. 연구자는 검증된 프로토콜을 이용하거나 다양한 조직 유형에 따라 워크플로우를 사용자 정의할 수 있어 효율성, 재현성, 데이터 신뢰성을 높이고 궁극적으로 암이나 면역학 등의 분야에서 조사를 가속화할 수 있습니다.

세계의 바이오엔지니어링 기술 시장은 세분화되고 있으며, 다수의 소규모 기업들이 진입하고 있습니다. 2024년 기준에서 시장 주요 10개사의 경쟁사가 시장 전체의 11.55%를 차지했습니다.

자주 묻는 질문

  • 바이오엔지니어링 기술 시장의 현재 규모는 얼마인가요?
  • 바이오엔지니어링 기술 시장의 성장률은 어떻게 되나요?
  • 2034년까지 바이오엔지니어링 기술 시장 규모는 어떻게 예상되나요?
  • 세포 치료에 대한 관심이 바이오엔지니어링 기술 시장에 미친 영향은 무엇인가요?
  • 바이오엔지니어링 기술 시장의 주요 기업은 어떤 혁신을 추구하고 있나요?
  • 자동 조직 분리 시스템의 역할은 무엇인가요?
  • 바이오엔지니어링 기술 시장의 경쟁 구도는 어떤가요?

목차

제1장 주요 요약

  • 바이오엔지니어링 기술 - 시장의 매력과 거시경제 환경

제2장 목차

제3장 표 일람

제4장 그림 일람

제5장 보고서 구성

제6장 시장 특징

  • 일반적인 시장의 정의
  • 개요
  • 바이오엔지니어링 기술 시장 정의와 세분화
  • 제품별 시장 세분화
    • 생체공학
    • 유전자 공학
    • 조직 공학
    • 생체 재료
    • 생체역학 공학
    • 나노생물공학
    • 기타 제품
  • 시장 세분화 : 기술별
    • 나노바이오기술
    • 조직 공학 및 재생
    • DNA 염기서열 분석
    • 세포 기반 분석법
    • 발효
    • 크로마토그래피
    • PCR 기술
    • 기타 기술
  • 시장 세분화 : 용도별
    • 헬스케어
    • 식품 및 농업
    • 천연자원 및 환경
    • 산업 공정 분야
    • 생물정보학 분야
    • 기타 용도 부문

제7장 주요 시장 동향

  • 자동 조직 해리 시스템이 세포 치료와 조사 효율을 향상
  • 차세대 벼농사 기술이 효율성과 내성을 실현
  • 시뮬레이션 기반의 툴이 의료기기 규제 분야에서 존재감 증가
  • 고성능 용도용으로 설계된 첨단 지속성 PTMEG
  • 최첨단 의지 기술이 저렴한 가격과 성능의 균형을 실현
  • 획기적인 장치가 생물학적 나노입자 분석에 일관성을 부여
  • AI를 활용한 오믹스 통합이 바이오메디컬이노베이션에 새로운 기준을 확립
  • AI 구동형 RNA 시퀀싱과 해석이 정밀의료 조사에 혁신 창출
  • 차세대 유전체 프로파일링이 액체 생검 기술 혁신에 의해 정밀 종양학을 변화
  • 초고속 NGS 기술이 체세포 암 분석에 혁신 창출
  • 차세대 플랫폼이 광학·전기 조직 해석에 의해 전임상 약물 시험을 강화

제8장 바이오엔지니어링 기술의 성장 분석 및 전략적 분석 프레임워크

  • 세계의 바이오엔지니어링 기술 PESTEL 분석(정치적, 사회적, 기술적, 환경적, 법적 요인)
    • 정치
    • 경제
    • 사회
    • 기술
    • 환경
    • 법적
  • 최종 사용자 분석(B2B)
    • 병원
    • 연구 및 학술 기관
    • 제약 및 생명 공학 기업
    • 진단실험실
    • 의료기기 제조업체
    • 기타 최종 사용자(계약연구기관(CRO), 정부·규제기관, 농업·식품가공기업)
  • 바이오엔지니어링 기술 시장 : 성장률 분석
  • 세계 시장 성장 실적(2019-2024년)
    • 시장 성장 촉진요인(2019-2024년)
    • 시장 성장 억제요인(2019-2024년)
  • 세계 시장 성장 예측(2024-2029년, 2034년)
  • 예측 성장 요인/기여 요소
    • 정량적 성장 요인
    • 성장 촉진요인
    • 성장 억제요인
  • 바이오엔지니어링 기술 : 전체 시장 규모(TAM)

제9장 바이오엔지니어링 기술 시장 : 세분화

  • 세계의 바이오엔지니어링 기술 시장 : 제품별, 분석과 예측(2019-2024년, 2029년, 2034년)
  • 세계의 바이오엔지니어링 기술 시장 : 기술별, 분석과 예측(2019-2024년, 2029년, 2034년)
  • 세계의 바이오엔지니어링 기술 시장 : 용도별, 분석과 예측(2019-2024년, 2029년, 2034년)
  • 세계의 바이오엔지니어링 기술 시장 : 생체의공학 유형별, 분석과 예측(2019-2024년, 2029년, 2034년)
  • 세계의 바이오엔지니어링 기술 시장 : 유전자 공학 유형별, 분석과 예측(2019-2024년, 2029년, 2034년)
  • 세계의 바이오엔지니어링 기술 시장 : 조직공학 유형별, 분석과 예측(2019-2024년, 2029년, 2034년)
  • 세계의 바이오엔지니어링 기술 시장 : 생체 재료 유형별, 분석과 예측(2019-2024년, 2029년, 2034년)
  • 세계의 바이오엔지니어링 기술 시장 : 생체 기계 공학 유형별, 분석과 예측(2019-2024년, 2029년, 2034년)
  • 세계의 바이오엔지니어링 기술 시장 : 나노 바이오 테크놀로지 유형별, 분석과 예측(2019-2024년, 2029년, 2034년)
  • 세계의 바이오엔지니어링 기술 시장 : 기타 제품 유형별, 분석과 예측(2019-2024년, 2029년, 2034년)

제10장 바이오엔지니어링 기술 시장 : 지역·국가별 분석

  • 바이오엔지니어링 기술 시장 : 지역별, 분석과 예측(2019-2024년, 2029년, 2034년)
  • 바이오엔지니어링 기술 시장 : 국가별, 분석과 예측(2019-2024년, 2029년, 2034년)

제11장 아시아태평양 시장

제12장 서유럽 시장

제13장 동유럽 시장

제14장 북미 시장

제15장 남미 시장

제16장 중동 시장

제17장 아프리카 시장

제18장 경쟁 구도와 기업 프로파일

  • 기업 프로파일
  • Thermo Fisher Scientific Inc
  • Roche Holding AG
  • Pfizer Inc
  • Illumina Inc
  • Agilent Technologies Inc

제19장 기타 주요 기업 및 혁신 기업

  • AstraZeneca plc
  • Lonza Group Ltd.
  • Moderna Inc.
  • Johnson & Johnson
  • Abbott Laboratories
  • Becton Dickinson(BD)
  • Bio-Rad Laboratories
  • Amgen Inc.
  • Regeneron Pharmaceuticals, Inc.
  • Biogen Inc.
  • Vertex Pharmaceuticals Inc.
  • Bristol-Myers Squibb Company
  • Novo Nordisk A/S
  • Gilead Sciences Inc.
  • Novartis AG

제20장 경쟁 벤치마킹

제21장 경쟁 대시보드

제22장 주요 인수합병(M&A)

  • Bio-Rad, Stilla Technologies 전략적 인수를 통해 글로벌 디지털 PCR 역량 확대
  • STEMCELL Technologies, Cellular Highways Ltd 인수
  • Thermo Fisher, Solventum 인수로 바이오제조 역량 강화
  • Yuhan Corporation, Progen 인수해 다중 표적 항체 치료제 개발 가속화
  • Ginkgo Bioworks, Fgen AG 인수해 생물공학 분야 리더십 공고화

제23장 바이오엔지니어링 기술 시장의 최근 동향 바이오엔지니어링 기술 시장

제24장 기회와 전략

  • 바이오엔지니어링 기술 시장(2029년) : 새로운 기회를 제공하는 국가
  • 바이오엔지니어링 기술 시장(2029년) : 새로운 기회를 제공하는 부문
  • 바이오엔지니어링 기술 시장(2029년) : 성장 전략
    • 시장 동향에 기초한 전략
    • 경쟁 전략

제25장 바이오엔지니어링 기술 시장 : 결론과 제안

  • 결론
  • 권고
    • 제품
    • 장소
    • 가격
    • 프로모션
    • 사람들

제26장 부록

KTH 25.12.12

Bioengineering technology is the application of engineering principles and techniques to biological systems and living organisms for the development of innovative products, processes and solutions in healthcare, agriculture and industry. It integrates disciplines such as biotechnology, materials science, electronics and computational modeling to address challenges in medicine, genetics, environmental sustainability and bio-manufacturing. The primary purpose of bioengineering technology is to improve human health, enhance quality of life and promote sustainability.

The global bioengineering technology market reached a value of nearly $320,380.84 million in 2024, having grown at a compound annual growth rate (CAGR) of 13.45% since 2019. The market is expected to grow from $320,380.84 million in 2024 to $565,164.47 million in 2029 at a rate of 12.02%. The market is then expected to grow at a CAGR of 10.26% from 2029 and reach $920,838.80 million in 2034.

Increasing Focus On Cell Therapies

Increasing focus on cell therapies propelled the growth of the bioengineering technology market during the historic period. The rising focus on cell therapies has fueled the bioengineering technology market as these therapies demand advanced tools for cell culture, genetic engineering and bioprocessing. Growing investments in regenerative medicine and personalized treatments are further driving innovation and adoption of bioengineering solutions. For instance, in April 2024, according to the American Society of Gene & Cell Therapy, a US-based organization for gene and cell therapy, in quarter four (Q4), the number of gene therapies in Phase III clinical trials increased by 10%, marking the first quarterly growth of this kind since quarter three (Q3) 2022. Therefore, increasing focus on cell therapies propelled the growth of the bioengineering technology market.

Automated Tissue Dissociation System Enhances Cell Therapy And Research Efficiency

Major companies in the bioengineering technology market are developing high viability and cell yield to improve the efficiency of cell-based therapies and biomanufacturing. These innovations aim to lower production costs, enhance scalability and accelerate the development of advanced therapeutics. For instance, in June 2025, STEMCELL Technologies, a Canada-based biotechnology company, launches the STEMprep Tissue Dissociator System, a benchtop instrument that automates and standardizes tissue dissociation, converting solid tissues into high-quality single-cell suspensions. Designed to save time and improve consistency, STEMprep preserves cell integrity and functionality, supporting accurate isolation and analysis. Researchers can utilize validated protocols or customize workflows across diverse tissue types, enhancing efficiency, reproducibility and data reliability, ultimately accelerating research in fields such as cancer and immunology.

The global bioengineering technology market is fragmented, with large number of small players operating in the market. The top 10 competitors in the market made up 11.55% of the total market in 2024.

Bioengineering Technology Global Market Opportunities And Strategies To 2034 from The Business Research Company provides the strategists; marketers and senior management with the critical information they need to assess the global bioengineering technology market as it emerges from the COVID-19 shut down.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market research findings.
  • Benchmark performance against key competitors.
  • Utilize the relationships between key data sets for superior strategizing.
  • Suitable for supporting your internal and external presentations with reliable high-quality data and analysis.

Where is the largest and fastest-growing market for bioengineering technology? How does the market relate to the overall economy; demography and other similar markets? What forces will shape the market going forward? The bioengineering technology market global report from The Business Research Company answers all these questions and many more.

The report covers market characteristics; size and growth; segmentation; regional and country breakdowns; competitive landscape; market shares; trends and strategies for this market. It traces the market's history and forecasts market growth by geography. It places the market within the context of the wider bioengineering technology market; and compares it with other markets.

The report covers the following chapters

  • Introduction And Market Characteristics- Brief introduction to the segmentations covered in the market, definitions and explanations about the segment by product, by technology and by application.
  • Key Trends- Highlights the major trends shaping the global market. This section also highlights likely future developments in the market.
  • Growth Analysis And Strategic Analysis Framework- Analysis on PESTEL, end use industries, market growth rate, global historic (2019-2024) and forecast (2024-2029, 2034F) market values and drivers and restraints that support and control the growth of the market in the historic and forecast periods, forecast growth contributors and total addressable market (TAM).
  • Regional And Country Analysis- Historic (2019-2024) and forecast (2024-2029, 2034F) market values and growth and market share comparison by region and country.
  • Market Segmentation- Contains the market values (2019-2024) (2024-2029, 2034F) and analysis for each segment by product, by technology and by application in the market. Historic (2019-2024) and forecast (2024-2029) and (2029-2034) market values and growth and market share comparison by region market.
  • Regional Market Size And Growth- Regional market size (2024), historic (2019-2024) and forecast (2024-2029, 2034F) market values and growth and market share comparison of countries within the region. This report includes information on all the regions Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa and major countries within each region.
  • Competitive Landscape- Details on the competitive landscape of the market, estimated market shares and company profiles of the leading players.
  • Other Major And Innovative Companies- Details on the company profiles of other major and innovative companies in the market.
  • Competitive Benchmarking- Briefs on the financials comparison between major players in the market.
  • Competitive Dashboard- Briefs on competitive dashboard of major players.
  • Key Mergers And Acquisitions- Information on recent mergers and acquisitions in the market covered in the report. This section gives key financial details of mergers and acquisitions, which have shaped the market in recent years.
  • Recent Developments- Information on recent developments in the market covered in the report.
  • Market Opportunities And Strategies- Describes market opportunities and strategies based on findings of the research, with information on growth opportunities across countries, segments and strategies to be followed in those markets.
  • Conclusions And Recommendations- This section includes recommendations for bioengineering technology providers in terms of product/service offerings geographic expansion, marketing strategies and target groups
  • Appendix- This section includes details on the NAICS codes covered, abbreviations and currencies codes used in this report.

Markets Covered:

  • 1) By Product: Biomedical Engineering; Genetic Engineering; Tissue Engineering; Biomaterial; Biomechanical Engineering; Nano-Biotechnology; Other Products
  • 2) By Technology: Nanobiotechnology; Tissue Engineering And Regeneration; DNA Sequencing; Cell-Based Assays; Fermentation; Chromatography; PCR Technology; Other Technologies
  • 3) By Application: Health; Food And Agriculture; Natural Resources And Environment; Industrial Processing; Bioinformatics; Other Applications
  • Companies Mentioned: Thermo Fisher Scientific; Roche Holding AG; Pfizer Inc.; Illumina, Inc; Agilent Technologies
  • Countries: China; Australia; India; Indonesia; Japan; South Korea; USA; Canada; Brazil; France; Germany; UK; Italy; Spain; Russia
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time-series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets; GDP proportions; expenditure per capita; bioengineering technology indicators comparison.
  • Data segmentations: country and regional historic and forecast data; market share of competitors; market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Table of Contents

1 Executive Summary

  • 1.1 Bioengineering Technology - Market Attractiveness And Macro Economic Landscape

2 Table Of Contents

3 List Of Tables

4 List Of Figures

5 Report Structure

6 Market Characteristics

  • 6.1 General Market Definition
  • 6.2 Summary
  • 6.3 Bioengineering Technology Market Definition And Segmentations
  • 6.4 Market Segmentation By Product
    • 6.4.1 Biomedical Engineering
    • 6.4.2 Genetic Engineering
    • 6.4.3 Tissue Engineering
    • 6.4.4 Biomaterial
    • 6.4.5 Biomechanical Engineering
    • 6.4.6 Nano-biotechnology
    • 6.4.7 Other Products
  • 6.5 Market Segmentation By Technology
    • 6.5.1 Nanobiotechnology
    • 6.5.2 Tissue Engineering And Regeneration
    • 6.5.3 DNA Sequencing
    • 6.5.4 Cell-Based Assays
    • 6.5.5 Fermentation
    • 6.5.6 Chromatography
    • 6.5.7 PCR Technology
    • 6.5.8 Other Technologies
  • 6.6 Market Segmentation By Application
    • 6.6.1 Health
    • 6.6.2 Food And Agriculture
    • 6.6.3 Natural Resources And Environment
    • 6.6.4 Industrial Processing Segment
    • 6.6.5 Bioinformatics Segment
    • 6.6.6 Other Applications Segment

7 Major Market Trends

  • 7.1 Automated Tissue Dissociation System Enhances Cell Therapy And Research Efficiency
  • 7.2 Next-Generation Rice Crops Deliver Efficiency And Resilience
  • 7.3 Simulation-Based Tool Gains Ground In Medical Device Regulation
  • 7.4 Advanced Sustainable PTMEG Designed For High-Performance Applications
  • 7.5 Cutting-Edge Prosthetic Technology Balances Affordability And Performance
  • 7.6 Breakthrough Device Delivers Consistency In Biological Nanoparticle Analysis
  • 7.7 AI-Powered Omics Integration Sets New Benchmark In Biomedical Innovation
  • 7.8 AI-Driven RNA Sequencing And Analysis Revolutionizes Precision Medicine Research
  • 7.9 Next-Generation Genomic Profiling Transforms Precision Oncology With Liquid Biopsy Innovation
  • 7.10 Ultra-Fast NGS Technology Revolutionizes Somatic Cancer Analysis
  • 7.11 Next-Gen Platforms Boost Preclinical Drug Testing with Optical and Electrical Tissue Analysis

8 Bioengineering Technology Growth Analysis And Strategic Analysis Framework

  • 8.1 Global Bioengineering Technology PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors)
    • 8.1.1 Political
    • 8.1.2 Economic
    • 8.1.3 Social
    • 8.1.4 Technological
    • 8.1.5 Environmental
    • 8.1.6 Legal
  • 8.2 Analysis Of End User (B2B)
    • 8.2.1 Hospitals
    • 8.2.2 Research And Academic Institutes
    • 8.2.3 Pharmaceutical And Biotechnology Companies
    • 8.2.4 Diagnostic Laboratories
    • 8.2.5 Medical Device Manufacturers
    • 8.2.6 Other Endusers (Contract Research Organizations (CROs), Government and Regulatory Agencies, Agriculture and Food Processing Companies)
  • 8.3 Bioengineering Technology Market Growth Rate Analysis
  • 8.4 Global Historic Market Growth, 2019 - 2024, Value ($ Million)
    • 8.4.1 Market Drivers 2019 - 2024
    • 8.4.2 Market Restraints 2019- 2024
  • 8.5 Global Forecast Market Growth, 2024 - 2029, 2034F Value ($ Million)
  • 8.6 Forecast Growth Contributors/Factors
    • 8.6.1 Quantitative Growth Contributors
    • 8.6.2 Drivers
    • 8.6.3 Restraints
  • 8.7 Bioengineering Technology Total Addressable Market (TAM)

9 Bioengineering Technology Market Segmentation

  • 9.1 Global Bioengineering Technology Market, Segmentation By Product, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 9.2 Global Bioengineering Technology Market, Segmentation By Technology, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 9.3 Global Bioengineering Technology Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 9.4 Global Bioengineering Technology Market, Sub-Segmentation Of Biomedical Engineering, By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 9.5 Global Bioengineering Technology Market, Sub-Segmentation Of Genetic Engineering, By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 9.6 Global Bioengineering Technology Market, Sub-Segmentation Of Tissue Engineering, By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 9.7 Global Bioengineering Technology Market, Sub-Segmentation Of Biomaterial, By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 9.8 Global Bioengineering Technology Market, Sub-Segmentation Of Biomechanical Engineering, By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 9.9 Global Bioengineering Technology Market, Sub-Segmentation Of Nano-Biotechnology, By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 9.10 Global Bioengineering Technology Market, Sub-Segmentation Of Other Products, By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)

10 Bioengineering Technology Market, Regional and Country Analysis

  • 10.1 Bioengineering Technology Market, By Region, Historic and Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 10.2 Bioengineering Technology Market, By Country, Historic and Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)

11 Asia-Pacific Market

  • 11.1 Summary
  • 11.2 Market Overview
    • 11.2.1 Region Information
    • 11.2.2 Market Information
    • 11.2.3 Background Information
    • 11.2.4 Government Initiatives
    • 11.2.5 Regulations
    • 11.2.6 Regulatory Bodies
    • 11.2.7 Major Associations
    • 11.2.8 Taxes Levied
    • 11.2.9 Corporate Tax Structure
    • 11.2.10 Investments
    • 11.2.11 Major Companies
  • 11.3 Asia-Pacific Bioengineering Technology Market, Segmentation By Product, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 11.4 Asia-Pacific Bioengineering Technology Market, Segmentation By Technology, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 11.5 Asia-Pacific Bioengineering Technology Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 11.6 China Market
  • 11.7 Summary
  • 11.8 Market Overview
    • 11.8.1 Country Information
    • 11.8.2 Market Information
    • 11.8.3 Background Information
    • 11.8.4 Government Initiatives
    • 11.8.5 Regulations
    • 11.8.6 Regulatory Bodies
    • 11.8.7 Major Associations
    • 11.8.8 Taxes Levied
    • 11.8.9 Corporate Tax Structure
    • 11.8.10 Investments
    • 11.8.11 Major Companies
  • 11.9 China Bioengineering Technology Market, Segmentation By Product, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 11.10 China Bioengineering Technology Market, Segmentation By Technology, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 11.11 China Bioengineering Technology Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 11.12 India Market
  • 11.13 India Bioengineering Technology Market, Segmentation By Product, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 11.14 India Bioengineering Technology Market, Segmentation By Technology, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 11.15 India Bioengineering Technology Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 11.16 Japan Market
  • 11.17 Summary
  • 11.18 Market Overview
    • 11.18.1 Country Information
    • 11.18.2 Market Information
    • 11.18.3 Background Information
    • 11.18.4 Government Initiatives
    • 11.18.5 Regulations
    • 11.18.6 Regulatory Bodies
    • 11.18.7 Major Associations
    • 11.18.8 Taxes Levied
    • 11.18.9 Corporate Tax Structure
    • 11.18.10 Investments
    • 11.18.11 Major Companies
  • 11.19 Japan Bioengineering Technology Market, Segmentation By Product, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 11.20 Japan Bioengineering Technology Market, Segmentation By Technology, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 11.21 Japan Bioengineering Technology Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 11.22 Australia Market
  • 11.23 Australia Bioengineering Technology Market, Segmentation By Product, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 11.24 Australia Bioengineering Technology Market, Segmentation By Technology, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 11.25 Australia Bioengineering Technology Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 11.26 Indonesia Market
  • 11.27 Indonesia Bioengineering Technology Market, Segmentation By Product, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 11.28 Indonesia Bioengineering Technology Market, Segmentation By Technology, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 11.29 Indonesia Bioengineering Technology Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 11.30 South Korea Market
  • 11.31 Summary
  • 11.32 Market Overview
    • 11.32.1 Country Information
    • 11.32.2 Market Information
    • 11.32.3 Background Information
    • 11.32.4 Government Initiatives
    • 11.32.5 Regulations
    • 11.32.6 Regulatory Bodies
    • 11.32.7 Major Associations
    • 11.32.8 Taxes Levied
    • 11.32.9 Corporate Tax Structure
    • 11.32.10 Investments
    • 11.32.11 Major Companies
  • 11.33 South Korea Bioengineering Technology Market, Segmentation By Product, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 11.34 South Korea Bioengineering Technology Market, Segmentation By Technology, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 11.35 South Korea Bioengineering Technology Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)

12 Western Europe Market

  • 12.1 Summary
  • 12.2 Market Overview
    • 12.2.1 Region Information
    • 12.2.2 Market Information
    • 12.2.3 Background Information
    • 12.2.4 Government Initiatives
    • 12.2.5 Regulations
    • 12.2.6 Regulatory Bodies
    • 12.2.7 Major Associations
    • 12.2.8 Taxes Levied
    • 12.2.9 Corporate tax structure
    • 12.2.10 Investments
    • 12.2.11 Major Companies
  • 12.3 Western Europe Bioengineering Technology Market, Segmentation By Product, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 12.4 Western Europe Bioengineering Technology Market, Segmentation By Technology, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 12.5 Western Europe Bioengineering Technology Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 12.6 Western Europe Bioengineering Technology Market: Country Analysis
  • 12.7 UK Market
  • 12.8 UK Bioengineering Technology Market, Segmentation By Product, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 12.9 UK Bioengineering Technology Market, Segmentation By Technology, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 12.10 UK Bioengineering Technology Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 12.11 Germany Market
  • 12.12 Germany Bioengineering Technology Market, Segmentation By Product, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 12.13 Germany Bioengineering Technology Market, Segmentation By Technology, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 12.14 Germany Bioengineering Technology Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 12.15 France Market
  • 12.16 France Bioengineering Technology Market, Segmentation By Product, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 12.17 France Bioengineering Technology Market, Segmentation By Technology, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 12.18 France Bioengineering Technology Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 12.19 Italy Market
  • 12.20 Italy Bioengineering Technology Market, Segmentation By Product, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 12.21 Italy Bioengineering Technology Market, Segmentation By Technology, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 12.22 Italy Bioengineering Technology Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 12.23 Spain Market
  • 12.24 Spain Bioengineering Technology Market, Segmentation By Product, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 12.25 Spain Bioengineering Technology Market, Segmentation By Technology, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 12.26 Spain Bioengineering Technology Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)

13 Eastern Europe Market

  • 13.1 Summary
  • 13.2 Market Overview
    • 13.2.1 Region Information
    • 13.2.2 Market Information
    • 13.2.3 Background Information
    • 13.2.4 Government Initiatives
    • 13.2.5 Regulations
    • 13.2.6 Regulatory Bodies
    • 13.2.7 Major Associations
    • 13.2.8 Taxes Levied
    • 13.2.9 Corporate Tax Structure
    • 13.2.10 Investments
    • 13.2.11 Major companies
  • 13.3 Eastern Europe Bioengineering Technology Market, Segmentation By Product, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 13.4 Eastern Europe Bioengineering Technology Market, Segmentation By Technology, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 13.5 Eastern Europe Bioengineering Technology Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 13.6 Eastern Europe Bioengineering Technology Market: Country Analysis
  • 13.7 Russia Market
  • 13.8 Russia Bioengineering Technology Market, Segmentation By Product, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 13.9 Russia Bioengineering Technology Market, Segmentation By Technology, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 13.10 Russia Bioengineering Technology Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)

14 North America Market

  • 14.1 Summary
  • 14.2 Market Overview
    • 14.2.1 Region Information
    • 14.2.2 Market Information
    • 14.2.3 Background Information
    • 14.2.4 Government Initiatives
    • 14.2.5 Regulations
    • 14.2.6 Regulatory Bodies
    • 14.2.7 Major Associations
    • 14.2.8 Taxes Levied
    • 14.2.9 Corporate Tax Structure
    • 14.2.10 Investments
    • 14.2.11 Major Companies
  • 14.3 North America Bioengineering Technology Market, Segmentation By Product, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 14.4 North America Bioengineering Technology Market, Segmentation By Technology, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 14.5 North America Bioengineering Technology Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 14.6 North America Bioengineering Technology Market: Country Analysis
  • 14.7 USA Market
  • 14.8 Summary
  • 14.9 Market Overview
    • 14.9.1 Country Information
    • 14.9.2 Market Information
    • 14.9.3 Background Information
    • 14.9.4 Government Initiatives
    • 14.9.5 Regulations
    • 14.9.6 Regulatory Bodies
    • 14.9.7 Major Associations
    • 14.9.8 Taxes Levied
    • 14.9.9 Corporate Tax Structure
    • 14.9.10 Investments
    • 14.9.11 Major Companies
  • 14.10 USA Bioengineering Technology Market, Segmentation By Product, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 14.11 USA Bioengineering Technology Market, Segmentation By Technology, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 14.12 USA Bioengineering Technology Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 14.13 Canada Market
  • 14.14 Summary
  • 14.15 Market Overview
    • 14.15.1 Country Information
    • 14.15.2 Market Information
    • 14.15.3 Background Information
    • 14.15.4 Government Initiatives
    • 14.15.5 Regulations
    • 14.15.6 Regulatory Bodies
    • 14.15.7 Major Associations
    • 14.15.8 Taxes Levied
    • 14.15.9 Corporate Tax Structure
    • 14.15.10 Investments
    • 14.15.11 Major Companies
  • 14.16 Canada Bioengineering Technology Market, Segmentation By Product, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 14.17 Canada Bioengineering Technology Market, Segmentation By Technology, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 14.18 Canada Bioengineering Technology Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)

15 South America Market

  • 15.1 Summary
  • 15.2 Market Overview
    • 15.2.1 Region Information
    • 15.2.2 Market Information
    • 15.2.3 Background Information
    • 15.2.4 Government Initiatives
    • 15.2.5 Regulations
    • 15.2.6 Regulatory Bodies
    • 15.2.7 Major Associations
    • 15.2.8 Taxes Levied
    • 15.2.9 Corporate Tax Structure
    • 15.2.10 Investments
    • 15.2.11 Major Companies
  • 15.3 South America Bioengineering Technology Market, Segmentation By Product, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 15.4 South America Bioengineering Technology Market, Segmentation By Technology, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 15.5 South America Bioengineering Technology Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 15.6 South America Bioengineering Technology Market: Country Analysis
  • 15.7 Brazil Market
  • 15.8 Brazil Bioengineering Technology Market, Segmentation By Product, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 15.9 Brazil Bioengineering Technology Market, Segmentation By Technology, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 15.10 Brazil Bioengineering Technology Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)

16 Middle East Market

  • 16.1 Summary
  • 16.2 Market Overview
    • 16.2.1 Region Information
    • 16.2.2 Market Information
    • 16.2.3 Background Information
    • 16.2.4 Government Initiatives
    • 16.2.5 Regulations
    • 16.2.6 Regulatory Bodies
    • 16.2.7 Major Associations
    • 16.2.8 Taxes Levied
    • 16.2.9 Corporate Tax Structure
    • 16.2.10 Investments
    • 16.2.11 Major Companies
  • 16.3 Middle East Bioengineering Technology Market, Segmentation By Product, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 16.4 Middle East Bioengineering Technology Market, Segmentation By Technology, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 16.5 Middle East Bioengineering Technology Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)

17 Africa Market

  • 17.1 Summary
  • 17.2 Market Overview
    • 17.2.1 Region Information
    • 17.2.2 Market Information
    • 17.2.3 Background Information
    • 17.2.4 Government Initiatives
    • 17.2.5 Regulations
    • 17.2.6 Regulatory Bodies
    • 17.2.7 Major Associations
    • 17.2.8 Taxes Levied
    • 17.2.9 Corporate Tax Structure
    • 17.2.10 Investments
    • 17.2.11 Major Companies
  • 17.3 Africa Bioengineering Technology Market, Segmentation By Product, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 17.4 Africa Bioengineering Technology Market, Segmentation By Technology, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 17.5 Africa Bioengineering Technology Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)

18 Competitive Landscape And Company Profiles

  • 18.1 Company Profiles
  • 18.2 Thermo Fisher Scientific Inc
    • 18.2.1 Company Overview
    • 18.2.2 Products And Services
    • 18.2.3 Business Strategy
    • 18.2.4 Financial Overview
  • 18.3 Roche Holding AG
    • 18.3.1 Company Overview
    • 18.3.2 Products And Services
    • 18.3.3 Business Strategy
    • 18.3.4 Financial Overview
  • 18.4 Pfizer Inc
    • 18.4.1 Company Overview
    • 18.4.2 Products And Services
    • 18.4.3 Business Strategy
    • 18.4.4 Financial Overview
  • 18.5 Illumina Inc
    • 18.5.1 Company Overview
    • 18.5.2 Products And Services
    • 18.5.3 Business Strategy
    • 18.5.4 Financial Overview
  • 18.6 Agilent Technologies Inc
    • 18.6.1 Company Overview
    • 18.6.2 Products And Services
    • 18.6.3 Business Strategy
    • 18.6.4 Financial Overview

19 Other Major And Innovative Companies

  • 19.1 AstraZeneca plc
    • 19.1.1 Company Overview
    • 19.1.2 Products And Services
  • 19.2 Lonza Group Ltd.
    • 19.2.1 Company Overview
    • 19.2.2 Products And Services
  • 19.3 Moderna Inc.
    • 19.3.1 Company Overview
    • 19.3.2 Products And Services
  • 19.4 Johnson & Johnson
    • 19.4.1 Company Overview
    • 19.4.2 Products And Services
  • 19.5 Abbott Laboratories
    • 19.5.1 Company Overview
    • 19.5.2 Products And Services
  • 19.6 Becton Dickinson (BD)
    • 19.6.1 Company Overview
    • 19.6.2 Products And Services
  • 19.7 Bio-Rad Laboratories
    • 19.7.1 Company Overview
    • 19.7.2 Products And Services
  • 19.8 Amgen Inc.
    • 19.8.1 Company Overview
    • 19.8.2 Products And Services
  • 19.9 Regeneron Pharmaceuticals, Inc.
    • 19.9.1 Company Overview
    • 19.9.2 Products And Services
  • 19.10 Biogen Inc.
    • 19.10.1 Company Overview
    • 19.10.2 Products And Services
  • 19.11 Vertex Pharmaceuticals Inc.
    • 19.11.1 Company Overview
    • 19.11.2 Products And Services
  • 19.12 Bristol-Myers Squibb Company
    • 19.12.1 Company Overview
    • 19.12.2 Products And Services
  • 19.13 Novo Nordisk A/S
    • 19.13.1 Company Overview
    • 19.13.2 Products And Services
  • 19.14 Gilead Sciences Inc.
    • 19.14.1 Company Overview
    • 19.14.2 Products And Services
  • 19.15 Novartis AG
    • 19.15.1 Company Overview
    • 19.15.2 Products And Services

20 Competitive Benchmarking

21 Competitive Dashboard

22 Key Mergers And Acquisitions

  • 22.1 Bio-Rad Expands Global Digital PCR Capabilities Through Strategic Acquisition of Stilla Technologies
  • 22.2 STEMCELL Technologies Acquired Cellular Highways Ltd
  • 22.3 Thermo Fisher Expands Biomanufacturing Edge With Solventum Acquisition
  • 22.4 Yuhan Corporation Acquires Progen To Advance Multi-Target Antibody Drug Development
  • 22.5 Ginkgo Bioworks Strengthens Bioengineering Leadership With Fgen AG Acquisition

23 Recent Developments In The Bioengineering Technology Market

  • 23.1 AI Platform Revolutionizes Access to Advanced Drug Discovery for Biotech Firms
  • 23.2 High-Yield AAV Platform Boosts Scalable Gene Therapy Manufacturing

24 Opportunities And Strategies

  • 24.1 Bioengineering Technology Market In 2029 - Countries Offering Most New Opportunities
  • 24.2 Bioengineering Technology Market In 2029 - Segments Offering Most New Opportunities
  • 24.3 Bioengineering Technology Market In 2029 - Growth Strategies
    • 24.3.1 Market Trend Based Strategies
    • 24.3.2 Competitor Strategies

25 Bioengineering Technology Market, Conclusions And Recommendations

  • 25.1 Conclusions
  • 25.2 Recommendations
    • 25.2.1 Product
    • 25.2.2 Place
    • 25.2.3 Price
    • 25.2.4 Promotion
    • 25.2.5 People

26 Appendix

  • 26.1 Geographies Covered
  • 26.2 Market Data Sources
  • 26.3 Research Methodology
  • 26.4 Currencies
  • 26.5 The Business Research Company
  • 26.6 Copyright and Disclaimer
샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제